Pulsed Field Ablation Innovator Argá Medtech Announces €54 Million Oversubscribed Series B Capital Raise - Funding will advance US and EU clinical studies of innovative pulsed field ablation system for treating atrial fibrillation - LAUSANNE, Switzerland and SAN DIEGO, Feb. 27, 2024 (GLOBE NEWSWIRE)...

Argá Medtech Initiates First-in-Human Trial to Assess the Safety and Effectiveness of Coherent Sine Wave Electroporation in Patients with Atrial Fibrillation Acute procedural success achieved in all patients using a novel pulsed field ablation (PFA) sine waveform and configurable catheter. EPALINGES, Switzerland, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Argá...

Argá Medtech Shows Promise for New Cardiac Ablation Technology at 2022 Heart Rhythm Society Annual Meeting Argá Medtech’s next-generation non-thermal cardiac ablation system shows promise in improving precision, speed and flexibility in treating atrial fibrillationPreliminary feasibility study results...